By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BG Medicine today lowered the expected share price for its proposed initial public offering to $7, the second time it has lowered its price since filing for the IPO a year ago.
Already have a GenomeWeb or 360Dx account?Login Now.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.
Futurism writes that gene doping could be the next generation of cheating in sports.
This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.
In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.
This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.